Medcom Acquired by Quintiles
TM Capital completed the sale of Medcom, Inc. to Quintiles Transnational Corp. (NASDAQ)
SteriGenics Acquires Irradiation Industries
TM Capital assisted SteriGenics International, Inc. (NASDAQ) in the strategic acquisition of Irradiation Industries, Inc.
Jensen Completes Recapitalization
TM Capital assisted Jensen Industries Inc. in completing a recapitalization transaction
Immucor Completes Debt Restructuring
TM Capital assisted Immucor, Inc. (NASDAQ) in restructuring $42 million of senior indebtedness
Immucor Board of Directors Re-Elected
TM Capital advised the Board of Directors of Immucor, Inc.(NASDAQ) in connection with a proxy contest in which all of Immucor’s directors were successfully re-elected
Epic Therapeutics Acquired by Baxter International
TM Capital advised Epic Therapeutics in its acquisition by Baxter Healthcare Corporation (NYSE:BAX) subsequent to a collaboration agreement and investment by Baxter
Portland Professional Acquired by NMHC
TM Capital completed the sale of Portland Professional Pharmacy to National Medical Health Card Systems, Inc. (NASDAQ)
Immucor Goodwill Valuation Analysis
TM Capital provided Immucor, Inc. (NASDAQ) with an analysis of goodwill balances for potential impairment pursuant to FAS 142
NanoGram Devices Acquired by Greatbatch
TM Capital advised NanoGram Devices Corporation in its sale to Greatbatch, Inc. (NYSE: GB) for $45 million in cash
Immucor Forms Joint Venture with Kainos
TM Capital assisted Immucor, Inc. (NASDAQ) in forming a joint venture for distribution of Immucor’s products in Japan with Kainos Laboratories, Inc.
